Long term treatment with simvastatin diminishes the migration capacity of prostate cancer cells through downregulation of urokinase plasminogen activator

Saved in:
Bibliographic Details
Published inEuropean urology open science (Online) Vol. 44; p. S162
Main Authors Kafka, M., Gruber, R., Neuwirt, H., Ladurner, M., Eder, I.E.
Format Journal Article
LanguageEnglish
Published 01.10.2022
Online AccessGet full text

Cover

More Information
ISSN:2666-1683
2666-1683
DOI:10.1016/S2666-1683(22)01929-2